ASCENDIS PHARMA A/S shareholders Q3 2023

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.

ASCENDIS PHARMA A/S shareholders Q3 2023
NameSharesValueWeighting ↓
TD ASSET MANAGEMENT INC 267,360$25,035,5900.03%
NEW YORK STATE COMMON RETIREMENT FUND 204,700$19,1680.03%
Virtu Financial LLC 2,995$2800.03%
Schonfeld Strategic Advisors LLC 38,900$3,642,5960.03%
THRIVENT FINANCIAL FOR LUTHERANS 115,454$10,8110.03%
ALLIANCEBERNSTEIN L.P. 602,874$56,453,1210.02%
AMERICAN CENTURY COMPANIES INC 329,274$30,833,1800.02%
DEUTSCHE BANK AG\ 361,029$33,806,7560.02%
PRICE T ROWE ASSOCIATES INC /MD/ 1,637,848$153,3690.02%
D. E. Shaw & Co., Inc. 220,553$20,652,5830.02%
Pictet Asset Management Holding SA 170,870$16,000,2670.02%
BALYASNY ASSET MANAGEMENT L.P. 94,868$8,883,4400.02%
Invesco Ltd. 672,126$62,937,8780.02%
Ensign Peak Advisors, Inc 67,544$6,324,8200.01%
TOBAM 1,810$1690.01%
PROFUND ADVISORS LLC 2,540$237,8460.01%
JENNISON ASSOCIATES LLC 159,434$14,929,4000.01%
ExodusPoint Capital Management, LP 13,743$1,2870.01%
Advisors Asset Management, Inc. 5,519$516,7990.01%
Aquatic Capital Management LLC 2,800$2620.01%
External links

This page lists ASCENDIS PHARMA A/S's shareholders in Q3 2023. To view ASCENDIS PHARMA A/S's shareholder history, click here.